Gorlin syndrome is characterized by genetic abnormalities in negative regulator molecules in the Hh pathway, most frequently PTCH1 [17,18] and, rarely, PTCH2 [19,20] and SUFU [21,22]. The gene discussed is PTCH1; the disease is nevoid basal cell carcinoma syndrome.